Letters

News article on report about drug researcher was biased

BMJ 2002; 324 doi: https://doi.org/10.1136/bmj.324.7337.612/a (Published 09 March 2002) Cite this as: BMJ 2002;324:612
  1. Elie Betito, director, public and government affairs
  1. Apotex, 150 Signet Drive, Toronto, Ontario, Canada M9L 1T9

    EDITOR—I wish to draw attention to an error in an article by Spurgeon.1 The drug company Apotex was sponsoring research into a new drug, deferiprone, and terminated a contract with one of the researchers because of several matters, but not as a result of her publishing her claims about the investigational drug.

    The researcher declared her intention to publish her claims only after the company had terminated her contract. Had Spurgeon contacted other parties involved in this controversy he would have realised that the information …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe